35 results
10-12G/A
RGPX
Regenerex Pharma, Inc.
6 Sep 17
Registration of securities (amended)
12:00am
expenses, products, projected costs and capital expenditures; research and development programs; sales and marketing initiatives; and competition. In some … is not considered reasonably assured at the time of sale, the Company does not recognize revenue until collection occurs.
Research and Development
10-12G/A
66fay qiip7v
18 Aug 17
Registration of securities (amended)
12:00am
8-K
uajmdlw10rzuopjw 225
26 Aug 14
Entry into a Material Definitive Agreement
12:00am